“Assessment Of Quality-Of-Life Improvement In Severe Haemophilia-A With Inhibitor Patients Receiving Emicizumab Prophylaxis – Hospital Based Prospective Observational Study - Original Research Article”, Rev Diabet Stud, pp. 579–583, Aug. 2025, doi: 10.70082/9n07nr44.